Literature DB >> 25101600

The role of palliative resection for asymptomatic primary tumor in patients with unresectable stage IV colorectal cancer.

Jung-A Yun1, Jung Wook Huh, Yoon Ah Park, Yong Beom Cho, Seong Hyeon Yun, Hee Cheol Kim, Woo Yong Lee, Ho-Kyung Chun.   

Abstract

BACKGROUND: The prognostic role of surgical resection of primary tumors is not well established in patients with asymptomatic unresectable stage IV colorectal cancer.
OBJECTIVE: The aims of this study were to reveal the prognostic role of surgical resection of primary tumors and to define prognostic factors affecting long-term oncological outcomes in patients with asymptomatic unresectable synchronous metastases.
DESIGN: This study was a retrospective analysis of prospectively collected data. PATIENTS: Between 2000 and 2008, a total of 416 patients with asymptomatic unresectable stage IV colorectal cancer were analyzed with propensity score matching. MAIN OUTCOME MEASURES: Prematching baseline characteristics were compared by bivariate analysis, and 113 pairs were selected after 1:1 matching with propensity scores estimated from logistic regression. The primary end point was overall survival.
RESULTS: Among 416 patients, 218 (52.4%) underwent palliative resection of the primary tumor. Before propensity score matching, palliative resection resulted in a better survival rate than nonresection in univariate analysis (p < 0.001), but not in multivariate analysis (p = 0.08). After matching, the 5-year overall survival rate was significantly lower for patients with peritoneal metastasis and clinical M1b stage tumors in univariate analysis (p = 0.004 and p = 0.02). However, neither peritoneal metastasis nor clinical M1b stage showed any prognostic significance in multivariate analysis. The overall 5-year survival rate of the postmatching group was 4.9% and 3.5% in the palliative resection and nonresection groups. Consequently, palliative resection was not associated with a significant increase in survival compared with nonresection (p = 0.27). A subgroup analysis performed according to the site of metastasis also did not show any significant survival benefit of palliative resection after matching. LIMITATIONS: Selection bias and potential confounders were limitations of this study.
CONCLUSIONS: Resection of the primary tumor in patients with asymptomatic unresectable stage IV colorectal cancer was not associated with an improvement in overall survival after propensity score matching.

Entities:  

Mesh:

Year:  2014        PMID: 25101600     DOI: 10.1097/DCR.0000000000000193

Source DB:  PubMed          Journal:  Dis Colon Rectum        ISSN: 0012-3706            Impact factor:   4.585


  20 in total

1.  Surgery: palliative primary tumour resection in mCRC-debate continues.

Authors:  Cornelis J H van de Velde
Journal:  Nat Rev Clin Oncol       Date:  2015-01-20       Impact factor: 66.675

Review 2.  Contemporary surgical options for metastatic colorectal cancer.

Authors:  Zhifei Sun; Julie M Thacker
Journal:  Curr Oncol Rep       Date:  2015-04       Impact factor: 5.075

3.  Benefit of Surgical Resection of the Primary Tumor in Patients Undergoing Chemotherapy for Stage IV Colorectal Cancer with Unresected Metastasis.

Authors:  Sean Maroney; Carlos Chavez de Paz; Mark E Reeves; Carlos Garberoglio; Elizabeth Raskin; Maheswari Senthil; Jukes P Namm; Naveenraj Solomon
Journal:  J Gastrointest Surg       Date:  2017-11-09       Impact factor: 3.452

4.  The influence of local therapy on the survival of patients with metastatic rectal cancer: a population-based, propensity-matched study.

Authors:  Chi-Hao Zhang; Yuan-Bo Pan; Qing-Wei Zhang; Ou-Min Shi; Lei Zheng; Liang Gui; Meng Luo
Journal:  J Cancer Res Clin Oncol       Date:  2017-05-22       Impact factor: 4.553

5.  Management of asymptomatic primary tumours in stage IV colorectal cancer: Review of outcomes.

Authors:  Kate Jessica Wilkinson; Wei Chua; Weng Ng; Aflah Roohullah
Journal:  World J Gastrointest Oncol       Date:  2015-12-15

6.  Primary Tumor Resection in Patients with Incurable Localized or Metastatic Colorectal Cancer: A Systematic Review and Meta-analysis.

Authors:  Constantinos Simillis; Eliana Kalakouti; Thalia Afxentiou; Christos Kontovounisios; Jason J Smith; David Cunningham; Michel Adamina; Paris P Tekkis
Journal:  World J Surg       Date:  2019-07       Impact factor: 3.352

7.  Comparative effectiveness of chemotherapy vs resection of the primary tumour as the initial treatment in older patients with Stage IV colorectal cancer.

Authors:  H B Mehta; G M Vargas; D Adhikari; F Dimou; T S Riall
Journal:  Colorectal Dis       Date:  2017-06       Impact factor: 3.788

8.  Surgical Resection of the Primary Tumor in Stage IV Colorectal Cancer Without Metastasectomy is Associated With Improved Overall Survival Compared With Chemotherapy/Radiation Therapy Alone.

Authors:  Brian C Gulack; Daniel P Nussbaum; Jeffrey E Keenan; Asvin M Ganapathi; Zhifei Sun; Mathias Worni; John Migaly; Christopher R Mantyh
Journal:  Dis Colon Rectum       Date:  2016-04       Impact factor: 4.585

9.  A scoring model for predicting survival following primary tumour resection in stage IV colorectal cancer patients with unresectable metastasis.

Authors:  S R Dorajoo; W J H Tan; S X Koo; W S Tan; M H Chew; C L Tang; H L Wee; C W Yap
Journal:  Int J Colorectal Dis       Date:  2015-10-21       Impact factor: 2.571

10.  Enhanced Recovery After Surgery (ERAS®) protocol in patients undergoing laparoscopic resection for stage IV colorectal cancer.

Authors:  Michał Pędziwiatr; Magdalena Pisarska; Michał Kisielewski; Piotr Major; Maciej Matłok; Mateusz Wierdak; Michał Natkaniec; Andrzej Budzyński
Journal:  World J Surg Oncol       Date:  2015-12-04       Impact factor: 2.754

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.